Engaging with life became exciting rather than daunting
FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
3 Semaglutide: A More Potent GLP-1RA for Weight Loss Semaglutide (Wegovy ) has emerged as a more effective alternative to liraglutide for the treatment of adolescent obesity, demonstrating greater reductions in body weight and improvements in cardiometabolic parameters
YOUR FUTURE
However, a Cochrane review concluded that benefits are more evident in children over 6 months old and in populations with high risk of zinc deficiency, with limited evidence for benefit in well-nourished or younger children (Lazzerini and Wanzira, 2016)
Glutathione homeostasis: crucial for abiotic stress tolerance in plants, in Abiotic stress adaptation in plants: physiological, molecular and genomic foundation
